EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
21,684,000
Total 13F shares
8,601,668
Share change
-183,620
Total reported value
$100,004,000
Price per share
$11.63
Number of holders
52
Value change
-$2,767,380
Number of buys
21
Number of sells
21

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q4 2021

As of 31 Dec 2021, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,601,668 shares. The largest 10 holders included COWEN AND COMPANY, LLC, WASATCH ADVISORS INC, Stonepine Capital Management, LLC, RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, SILVERCREST ASSET MANAGEMENT GROUP LLC, PLATINUM INVESTMENT MANAGEMENT LTD, and PERKINS CAPITAL MANAGEMENT INC. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.